| Name | Role | Date | Shares | Price | Value |
|---|---|---|---|---|---|
| Srinivas Akkaraju | Director | 2026-09-08 | 273,290 | $10.63 | $2.90MBuy |
| Srinivas Akkaraju | Director | 2026-09-08 | 48,065 | $10.55 | $506.99kSell |
| Srinivas Akkaraju | Director | 2026-09-08 | 273,291 | $10.63 | $2.90MBuy |
| Srinivas Akkaraju | Director | 2026-09-08 | 48,066 | $10.55 | $507.00kSell |
| Srinivas Akkaraju | Director | 2026-09-04 | 220,070 | $11.17 | $2.46MBuy |
| Srinivas Akkaraju | Director | 2026-09-04 | 220,070 | $11.17 | $2.46MBuy |
| Mark Christopher Bradley | CXO | 2026-08-03 | 2,572 | $26.37 | $67.82kSell |
| David M. Goldstein | CSci | 2026-08-03 | 2,596 | $26.37 | $68.46kSell |
| Roy C. Hardiman | CStrat | 2026-08-03 | 2,692 | $26.37 | $70.99kSell |
| Jorn Drappa | Med | 2026-08-03 | 2,447 | $26.37 | $64.53kSell |
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| Ayurmaya Capital Management Company LP | 11.70% | 15,139,707 | $96.59M | Insider |
| Srinivas Akkaraju | 10.50% | 13,584,581 | $86.67M | Insider |
| Foresite Capital Management VI LLC | 1.51% | 1,960,337 | $12.51M | Insider |
| James B. Tananbaum | 1.51% | 1,960,337 | $12.51M | Insider |
| Foresite Labs LLC | 1.51% | 1,960,337 | $12.51M | Insider |
| Foresite Capital Management V LLC | 0.91% | 1,176,470 | $7.51M | Insider |
| David M. Goldstein | 0.36% | 465,432 | $2.97M | Insider |
| Roy C. Hardiman | 0.17% | 220,580 | $1.41M | Insider |
| Martin Babler | 0.08% | 109,454 | $698.32k | Insider |
| Mark Christopher Bradley | 0.07% | 88,585 | $565.17k | Insider |